date: 2016-11-21 16:49:16 click:
From November 16th to 19th, 2016, Dr. Hu Zhuohan (first from left), the general manager of the company, was invited to participate in the 14th International Conference of New Drug Inventions and Technology held in Nanjing (the 80th anniversary of the establishment of China Pharmaceutical University). Seven Chapters - Clinical Trials, Drug Administrative Approval, and Market Development. He also gave a keynote speech on "In Vitro ADME Evaluation for Supporting IND Submissions in China: Guidance, Challenge and Solutions". Dr. Chang Yan from the National Shanghai New Drug Safety Evaluation Research Center (second from left) and Dr. Liu Dongyang from the Beijing Union Hospital (first from right) gave a keynote report on the pre-clinical safety evaluation of the IND declaration and the clinical evaluation supporting NDA.